USD $453.42
EXJADE is a medication used to treat chronic iron overload due to blood transfusions in patients aged 2 years and older. It is also indicated for patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.
EXJADE functions by binding to excess iron in the body, forming a complex that is excreted primarily through the feces. This process helps in reducing the chronic iron overload that can occur due to repeated blood transfusions.
EXJADE is beneficial for patients who have chronic iron overload due to blood transfusions, particularly those with conditions such as thalassemia, sickle cell anemia, or myelodysplastic syndromes. It is also suitable for patients with non-transfusion-dependent thalassemia syndromes.
EXJADE is taken orally, with the recommended dosage prescribed by a healthcare provider based on the patient's weight and iron levels. It is essential to follow the prescribed dosage and administration guidelines to ensure optimal effectiveness.
Some patients may experience side effects, including nausea, vomiting, diarrhea, abdominal pain, or skin rash. It is crucial to consult a healthcare provider if any severe side effects or allergic reactions occur.
Patients should inform their healthcare provider about all medications they are taking, as EXJADE may interact with certain drugs. A healthcare professional will provide guidance on any necessary adjustments or precautions.
Regular monitoring of liver and kidney function, as well as auditory and visual testing, is recommended during treatment. Patients should also maintain regular check-ups with their healthcare provider to ensure safe and effective use of EXJADE.
For additional details or specific medical advice, it is recommended to consult a healthcare professional or visit the manufacturer's official website for comprehensive product information.
Health Guides